Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

SZSE:300760.SZ

256.8 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q3
Revenue 11,036.379,272.0037,550.0638,828.02410,111.4928,364.2827,069.8137,940.2558,412.4676,943.1095,878.0696,613.1656,997.2985,781.054,962.1885,499.2925,823.1014,741.2674,176.5324,173.8874,299.6463,905.9263,473.5483,471.4223,572.1053,236.2832,828.8742,869.662
Cost of Revenue 3,988.2133,190.1312,763.3772,894.8673,545.5492,810.6792,568.9352,808.333,085.0342,422.992,172.9072,270.4072,377.482,021.9212,038.7731,731.4731,913.5981,682.2511,448.551,453.7121,516.9841,335.8121,194.8151,199.9671,179.9061,022.711969.366931.499
Gross Profit 7,048.1576,081.8714,786.6865,933.1576,565.9435,553.6034,500.8785,131.9245,327.4334,520.1193,705.1624,342.7584,619.8183,759.1282,923.4153,767.8193,909.5033,059.0162,727.9822,720.1752,782.6622,570.1142,278.7332,271.4552,392.1992,213.5721,859.5081,938.163
Gross Profit Ratio 0.6390.6560.6340.6720.6490.6640.6370.6460.6330.6510.630.6570.660.650.5890.6850.6710.6450.6530.6520.6470.6580.6560.6540.670.6840.6570.675
Reseach & Development Expenses 711.794947.432835.343657.494999.129852.301835.235737.297646.137703.945894.82567.885473.555587.918518.701447.191421.889481.518381.371378.863361.52343.857298.25329.026359.492280.391264.039200.711
General & Administrative Expenses -286.662473.351-663.294941.484-282.775457.085-568.947808.99-236.476358.377-503.721685.613-166.7324.666-411.587221.469-161.805271.92-360.322176.605-69.716160.282-322.811179.486168.495466.832-345.424171.071
Selling & Marketing Expenses 1,449.4741,485.4851,713.5581,154.7841,460.7621,373.821,471.0891,178.431,079.0861,072.951,155.327968.564923.438951.618783.972912.786965.377949.552996.981903.087904.32801.28860.131821.254845.149675.699768.504635.811
SG&A 1,732.7082,025.2492,199.9212,096.2681,177.9871,830.905902.1421,987.42842.611,431.327651.6061,654.177756.7381,276.285372.3851,134.255803.5711,221.472636.6591,079.692834.603961.562537.321,000.7411,013.6441,142.532423.08806.883
Other Expenses -47.691-43.449-409.453-26.70825.084-114.972910.893-567.359417.595-34.549675.565-540.619-3.633-2.54-29.29-6.0749.0989.547-19.2047.0682.859-1.26197.66710.313-6.729-2.1227.25417.046
Operating Expenses 2,492.1933,016.133,444.7162,078.0662,690.4442,568.2332,648.272,157.3581,906.3422,100.7232,221.9911,681.4431,610.881,821.6441,445.281,563.9971,502.4881,607.7751,497.4161,438.671,453.9371,2731,287.7981,288.3311,328.6571,074.8541,159.407944.426
Operating Income 4,555.9653,065.7411,341.973,870.7244,430.2832,899.6851,771.4253,213.8273,603.7282,401.5361,470.5192,672.7433,017.2531,905.2021,450.6412,095.8492,437.4421,471.2281,170.6111,475.9051,567.8121,164.464954.5641,140.4571,227.235955.899620.798852.871
Operating Income Ratio 0.4130.3310.1780.4380.4380.3470.2510.4050.4280.3460.250.4040.4310.330.2920.3810.4190.310.280.3540.3650.2980.2750.3290.3440.2950.2190.297
Total Other Income Expenses Net 438.882495.072486.776.468-8.092-12.084-46.1466.224-1.2124.17-36.869-5.594.683-34.823-56.784-114.04839.52529.534-79.16201.468241.945-133.911-77.665167.647-4,449.163-184.94-52.05-123.82
Income Before Tax 4,994.8463,560.8141,828.743,877.1924,422.1912,887.61,725.2793,220.0513,602.5152,405.7061,433.6492,667.1533,013.6211,902.6621,421.3512,089.7752,446.541,480.7741,151.4061,482.9731,570.6711,163.203913.271,150.7711,220.506953.779648.052869.917
Income Before Tax Ratio 0.4530.3840.2420.4390.4370.3450.2440.4060.4280.3460.2440.4030.4310.3290.2860.380.420.3120.2760.3550.3650.2980.2630.3310.3420.2950.2290.303
Income Tax Expense 569.683395.92481.059484.879551.317315.261220.347404.551419.203298.73394.93347.327383.652187.129126.031179.411306.393167.001140.242179.281206.666157.24889.573124.488153.924144.59951.94878.442
Net Income 4,400.8393,159.8991,747.9223,392.3133,870.8742,571.1171,504.842,814.6823,182.582,105.0721,338.672,318.4542,629.3931,715.0361,294.521,909.5282,140.3511,313.2771,009.4651,302.0911,363.3891,005.702822.5971,024.9481,064.499807.191595.203788.34
Net Income Ratio 0.3990.3410.2320.3840.3830.3070.2130.3540.3780.3030.2280.3510.3760.2970.2610.3470.3680.2770.2420.3120.3170.2570.2370.2950.2980.2490.210.275
EPS 3.642.611.442.83.192.131.242.332.631.741.11.912.161.411.061.571.761.080.831.071.130.830.750.940.980.740.540.72
EPS Diluted 3.642.611.442.83.192.121.242.322.631.741.11.912.161.411.061.571.761.080.831.071.130.830.750.940.980.740.540.72
EBITDA 4,891.0713,546.331,610.4663,861.944,468.5012,980.6721,777.6513,240.8483,636.5282,432.3331,451.5672,700.1783,050.091,935.8591,481.6172,242.9262,478.8841,478.7891,577.4551,296.7771,463.071,305.8711,069.4281,173.0675,669.671,114.287677.846947.412
EBITDA Ratio 0.4430.3820.2130.4370.4420.3560.2510.4080.4320.350.2470.4080.4360.3350.2990.4080.4260.3120.3780.3110.340.3340.3080.3381.5870.3440.240.33